InnoPharmax Inc. (TPEX:4172)
Taiwan · Delayed Price · Currency is TWD 11.00
-0.25 (-2.22%)
Sep 8, 2026, 1:58 PM CST
InnoPharmax Market Cap
InnoPharmax has a market cap or net worth of 1.33 billion as of September 4, 2026. Its market cap has decreased by -36.93% in one year.
Market Cap
1.33B
Enterprise Value
1.09B
Revenue
67.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.00
ChartMarket Cap Chart
Since September 13, 2012, InnoPharmax's market cap has decreased from 1.54B to 1.33B, a decrease of -13.52%. That is a compound annual growth rate of -1.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 1.33B | -26.23% |
| Dec 31, 2025 | 1.81B | 3.38% |
| Dec 31, 2024 | 1.75B | 5.76% |
| Dec 29, 2023 | 1.65B | 62.70% |
| Dec 30, 2022 | 1.02B | -32.67% |
| Dec 30, 2021 | 1.51B | 15.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merdury Biopharmaceutical | 2.35B |
| PhytoHealth | 2.26B |
| Johnson Chemical Pharmaceutical Works | 2.26B |
| TSH Biopharm Corporation | 1.95B |
| GeneFerm Biotechnology | 1.25B |
| Excelsior Biopharma | 1.14B |
| Prince Pharmaceutical | 1.06B |
| DV Biomed | 999.53M |